← Back to patent-cliff list
Bisoprolol Fructoheptonate
Tier C — Watch / tradeBisoprolol Fructoheptonate
Pfizer Ltd
Originator
2011
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRB1
Brand：Bisoprolol
Indications (approved)：高血压、稳定型心绞痛
Regional status
US
-
EU
批准上市
2011-10-06
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bisoprolol Fructoheptonate?
Approved indications include: 高血压, 稳定型心绞痛.
When does the Bisoprolol Fructoheptonate patent expire?
No public expiry year is available for Bisoprolol Fructoheptonate yet; this page updates once verified.
How do I get a quote for Bisoprolol Fructoheptonate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24